[The results of 2 and 1/2 years of work of the Russian Multicenter Trial on the Treatment of Acute Myeloid Leukemias in Adults].
D000208:Acute Disease; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D018572:Disease-Free Survival; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D015122:Mercaptopurine / Q000008:administration & dosage; D012074:Remission Induction; D012426:Russia / Q000453:epidemiology; D016019:Survival Analysis; D013997:Time Factors
D003561:Cytarabine; D005047:Etoposide; D003520:Cyclophosphamide; D015122:Mercaptopurine; D003630:Daunorubicin
Itogi dvukh s polovinoĭ let raboty Rossiĭskogo mnogotsentrovogo issledovaniia po lecheniiu ostrykh mieloidnykh leĭkozov vzroslykh.